Takeda's Pipeline Cleanup Leads to Layoffs and Program Cuts.
Takeda is ending its seven-year partnership with Theravance and cutting a partnered Crohn's program after a Phase IIb failure. The company is also cutting seven clinical trials for various diseases and cancers and plans to lay off over 180 workers.